Trials / Completed
CompletedNCT01068600
Comparison of Efficacy of Indacaterol Versus Placebo Over 12 Weeks
A 12-week Treatment, Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Once Daily Indacaterol in Patients With Chronic Obstructive Pulmonary Disease
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 318 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
This 12-week study evaluated the efficacy and safety of indacaterol versus placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Indacaterol | Once daily via single-dose dry powder inhaler (SDDPI) |
| DRUG | Placebo to indacaterol | Once daily via SDDPI |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2010-06-01
- First posted
- 2010-02-15
- Last updated
- 2011-08-19
- Results posted
- 2011-08-19
Locations
54 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01068600. Inclusion in this directory is not an endorsement.